Academic Journal

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.

التفاصيل البيبلوغرافية
العنوان: Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
المؤلفون: Zimmer, Sebastian, Grebe, Alena, Bakke, Siril S, Bode, Niklas, Halvorsen, Bente, Ulas, Thomas, Skjelland, Mona, De Nardo, Dominic, Labzin, Larisa I, Kerksiek, Anja, Hempel, Chris, HENEKA, Michael, Hawxhurst, Victoria, Fitzgerald, Michael L, Trebicka, Jonel, Björkhem, Ingemar, Gustafsson, Jan-Åke, Westerterp, Marit, Tall, Alan R, Wright, Samuel D, Espevik, Terje, Schultze, Joachim L, Nickenig, Georg, Lütjohann, Dieter, Latz, Eicke
المصدر: Science Translational Medicine, 8 (333), 333ra50 (2016-04-06)
بيانات النشر: American Association for the Advancement of Science
سنة النشر: 2016
المجموعة: University of Luxembourg: ORBilu - Open Repository and Bibliography
مصطلحات موضوعية: Liver X Receptors, beta-Cyclodextrins, 2-Hydroxypropyl-beta-cyclodextrin, Cholesterol, Animals, Atherosclerosis/drug therapy, Atherosclerosis/genetics, Atherosclerosis/pathology, Biological Transport/drug effects, Cholesterol/metabolism, Crystallization, Gene Expression Regulation/drug effects, Humans, Liver X Receptors/metabolism, Macrophages/drug effects, Macrophages/metabolism, Mice, Plaque, Atherosclerotic/drug therapy, Atherosclerotic/genetics, Atherosclerotic/pathology, beta-Cyclodextrins/pharmacology, beta-Cyclodextrins/therapeutic use, Atherosclerosis, Biological Transport, Gene Expression Regulation, Macrophages, Atherosclerotic, Medicine (all), General Medicine
الوصف: peer reviewed ; Atherosclerosis is an inflammatory disease linked to elevated blood cholesterol concentrations. Despite ongoing advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains the leading cause of death worldwide. Continuous retention of apolipoprotein B-containing lipoproteins in the subendothelial space causes a local overabundance of free cholesterol. Because cholesterol accumulation and deposition of cholesterol crystals (CCs) trigger a complex inflammatory response, we tested the efficacy of the cyclic oligosaccharide 2-hydroxypropyl-β-cyclodextrin (CD), a compound that increases cholesterol solubility in preventing and reversing atherosclerosis. We showed that CD treatment of murine atherosclerosis reduced atherosclerotic plaque size and CC load and promoted plaque regression even with a continued cholesterol-rich diet. Mechanistically, CD increased oxysterol production in both macrophages and human atherosclerotic plaques and promoted liver X receptor (LXR)-mediated transcriptional reprogramming to improve cholesterol efflux and exert anti-inflammatory effects. In vivo, this CD-mediated LXR agonism was required for the antiatherosclerotic and anti-inflammatory effects of CD as well as for augmented reverse cholesterol transport. Because CD treatment in humans is safe and CD beneficially affects key mechanisms of atherogenesis, it may therefore be used clinically to prevent or treat human atherosclerosis.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 1946-6234
1946-6242
Relation: urn:issn:1946-6234; urn:issn:1946-6242; https://orbilu.uni.lu/handle/10993/61027; info:hdl:10993/61027; https://orbilu.uni.lu/bitstream/10993/61027/1/Cyclodextrin%20promotes%20atherosclerosis%20regression%20via%20macrophage%20reprogramming.pdf; info:pmid:27053774; wos:000374240300005
DOI: 10.1126/scitranslmed.aad6100
الاتاحة: https://orbilu.uni.lu/handle/10993/61027
https://orbilu.uni.lu/bitstream/10993/61027/1/Cyclodextrin%20promotes%20atherosclerosis%20regression%20via%20macrophage%20reprogramming.pdf
https://doi.org/10.1126/scitranslmed.aad6100
Rights: open access ; http://purl.org/coar/access_right/c_abf2 ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.CAED03B1
قاعدة البيانات: BASE
الوصف
تدمد:19466234
19466242
DOI:10.1126/scitranslmed.aad6100